Intravitreal Aflibercept Therapy and Treatment Outcomes of Eyes with Neovascular Age-Related Macular Degeneration in a Real-Life Setting: A Five-Year Follow-Up Investigation

被引：0
|
作者：
Reinhard Angermann
Alexander Franchi
Victoria Stöckl
Julia Rettenwander
Tanja Rettenwander
David Goldin
Martin Stattin
Martina T. Kralinger
Claus Zehetner
机构：
[1] Medical University Innsbruck,Department of Ophthalmology
[2] Paracelsus Medical University Salzburg,Department of Ophthalmology
[3] Clinic Landstraße,Department of Ophthalmology
[4] Vienna Healthcare Group,undefined
[5] Karl Landsteiner Institute for Retinal Research and Imaging,undefined
来源：
Ophthalmology and Therapy | 2022年 / 11卷
关键词：
Anti-VEGF; Compliance; Macular degeneration; Nonpersistence; Vision loss;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：559 / 571
页数：12
相关论文
共 50 条
  • [1] Intravitreal Aflibercept Therapy and Treatment Outcomes of Eyes with Neovascular Age-Related Macular Degeneration in a Real-Life Setting: A Five-Year Follow-Up Investigation
    Angermann, Reinhard
    Franchi, Alexander
    Stoeckl, Victoria
    Rettenwander, Julia
    Rettenwander, Tanja
    Goldin, David
    Stattin, Martin
    Kralinger, Martina T.
    Zehetner, Claus
    OPHTHALMOLOGY AND THERAPY, 2022, 11 (02) : 559 - 571
  • [2] Pharmacogenetic Aspect of Intravitreal Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Five-Year Follow-Up
    Sengul, Elvan Alper
    Artunay, Ozgur
    Rasier, Rifat
    Kockar, Alev
    Afacan, Ceyda
    Hancer, Veysel Sabri
    Yuzbasioglu, Erdal
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2018, 26 (06) : 971 - 977
  • [3] Four-year outcomes of aflibercept treatment for neovascular age-related macular degeneration: Results from real-life setting
    Lukic, Marko
    Eleftheriadou, Maria
    Hamilton, Robin D.
    Rajendram, Ranjan
    Bucan, Kajo
    Patel, Praveen J.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (04) : 1940 - 1944
  • [4] Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes
    Meidong Zhu
    Jamie K. Chew
    Geoffrey K. Broadhead
    Kehui Luo
    Nichole Joachim
    Thomas Hong
    Adil Syed
    Andrew A. Chang
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2015, 253 : 1217 - 1225
  • [5] Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes
    Zhu, Meidong
    Chew, Jamie K.
    Broadhead, Geoffrey K.
    Luo, Kehui
    Joachim, Nichole
    Hong, Thomas
    Syed, Adil
    Chang, Andrew A.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 253 (08) : 1217 - 1225
  • [6] Ranibizumab for exudative age-related macular degeneration: A five year study of adherence to follow-up in a real-life setting
    Boulanger-Scemama, E.
    Querques, G.
    About, F.
    Puche, N.
    Srour, M.
    Mane, V.
    Massannba, N.
    Canoui-Poitrine, F.
    Souied, E. H.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2015, 38 (07): : 620 - 627
  • [7] Treatment of neovascular age-related macular degeneration: one year real-life results with intravitreal Brolucizumab
    Rossi, Settimio
    Gesualdo, Carlo
    Marano, Ernesto
    Perrotta, Raffaele
    Trotta, Maria Consiglia
    Del Giudice, Antonio
    Simonelli, Francesca
    FRONTIERS IN MEDICINE, 2025, 11
  • [8] Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better
    Khanani, Arshad M.
    Gahn, Greggory M.
    Koci, Micaela M.
    Dang, Jonathan M.
    Brown, Sandra M.
    Hill, Lauren F.
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 347 - 351
  • [9] Five-year treatment outcomes following intravitreal ranibizumab injections for neovascular age-related macular degeneration in Japanese patients
    Iori Wada
    Yuji Oshima
    Satomi Shiose
    Kumiko Kano
    Shintaro Nakao
    Yoshihiro Kaizu
    Shigeo Yoshida
    Tatsuro Ishibashi
    Koh-hei Sonoda
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2019, 257 : 1411 - 1418
  • [10] Five-year treatment outcomes following intravitreal ranibizumab injections for neovascular age-related macular degeneration in Japanese patients
    Wada, Iori
    Oshima, Yuji
    Shiose, Satomi
    Kano, Kumiko
    Nakao, Shintaro
    Kaizu, Yoshihiro
    Yoshida, Shigeo
    Ishibashi, Tatsuro
    Sonoda, Koh-hei
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (07) : 1411 - 1418
12345